Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Sandmann S, Unger T
L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil
Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201

PDF    Summary    Overview   

First Image Fig. 6: Kalziumkanal - Mibefradil Fig. 7: Kalziumkanal - Mibefradil Fig. 8A-B: Kalziumkanal - Mibefradil Fig. 9: Kalziumkanal - Mibefradil This Image - Fig. 10: Kalziumkanal - Mibefradil Fig. 11: Kalziumkanal - Mibefradil Fig. 12: Kalziumkanal - Mibefradil Fig. 13: Kalziumkanal - Mibefradil
Figure/Graphic 10: Kalziumkanal - Mibefradil
Cumulative percent survival of rats with chronic heart failure, either untreated (circle, n = 68) or treated with mibefradil (15 mg/kg/d, n = 59, white triangle) or cilazapril (10 mg/kg/d, n = 59, black triangle)
 
Kalziumkanal - Mibefradil
Previous Image Next Image   


Figure/Graphic 10: Kalziumkanal - Mibefradil
Cumulative percent survival of rats with chronic heart failure, either untreated (circle, n = 68) or treated with mibefradil (15 mg/kg/d, n = 59, white triangle) or cilazapril (10 mg/kg/d, n = 59, black triangle)
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung